Literature DB >> 18424267

Airway ion transport impacts on disease presentation and severity in cystic fibrosis.

Teresinha Leal1, Isabelle Fajac, Helen L Wallace, Patrick Lebecque, Jean Lebacq, Dominique Hubert, Josette Dall'Ava, Daniel Dusser, Anusha P Ganesan, Christiane Knoop, Jean Cumps, Pierre Wallemacq, Kevin W Southern.   

Abstract

OBJECTIVES: Abnormal airway ion transport is a feature of cystic fibrosis. The aim of this study was to investigate whether distinct components of ion transport are associated with the clinical expression and severity of the disease. DESIGN AND METHODS: Univariate and multivariate analyses were used to study interaction effects between nasal potential difference parameters and clinical status, recorded at stable conditions, in 75 F508del homozygous young adults.
RESULTS: All patients demonstrated increased sodium and reduced chloride conductances. Less sodium transport abnormalities were related to better respiratory function and nutrition. Presentation with digestive symptoms at diagnosis was associated with lower chloride conductance. With an accuracy of 85% good nutritional status was linked to more preserved lung function, increasing age and more preserved chloride conductance.
CONCLUSIONS: Ion transport abnormalities have distinct clinical outcomes. Sodium conductance relates to respiratory function and nutrition; chloride conductance to nutrition and presentation with digestive symptoms at diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424267     DOI: 10.1016/j.clinbiochem.2008.03.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Modular microfluidic system as a model of cystic fibrosis airways.

Authors:  M Skolimowski; M Weiss Nielsen; F Abeille; P Skafte-Pedersen; D Sabourin; A Fercher; D Papkovsky; S Molin; R Taboryski; C Sternberg; M Dufva; O Geschke; J Emnéus
Journal:  Biomicrofluidics       Date:  2012-08-02       Impact factor: 2.800

2.  Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology.

Authors:  Elenara da Fonseca Andrade Procianoy; Fernando Antônio de Abreu E Silva; Paulo José Cauduro Maróstica; Paul M Quinton
Journal:  Lung       Date:  2019-11-16       Impact factor: 2.584

Review 3.  On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis.

Authors:  Marjolein Ensinck; Angélique Mottais; Claire Detry; Teresinha Leal; Marianne S Carlon
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

4.  Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation.

Authors:  Steven M Rowe; Bo Liu; Aubrey Hill; Heather Hathorne; Morty Cohen; John R Beamer; Frank J Accurso; Qunming Dong; Claudia L Ordoñez; Anne J Stone; Eric R Olson; John P Clancy
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

5.  Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study.

Authors:  Azadeh Bagheri-Hanson; Sebastian Nedwed; Claudia Rueckes-Nilges; Lutz Naehrlich
Journal:  BMC Pulm Med       Date:  2014-10-04       Impact factor: 3.317

6.  Repeatability and Diagnostic Value of Nasal Potential Difference in a Genetically Admixed Population.

Authors:  Izabela Rocha Sad; Laurinda Yoko Shinzato Higa; Teresinha Leal; Raisa da Silva Martins; Ana Claudia de Almeida; Eloane Goncalves Ramos; Giselda Maria Kalil de Cabello; Maria Virginia Marques Peixoto
Journal:  J Clin Med Res       Date:  2015-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.